77Fig. 3.9 Improvement in RAPID3 (routine assessment of patient index data 3) scores over
2 months in patients with 5 rheumatic diseases: rheumatoid arthritis (RA), osteoarthritis (OA),
systemic lupus erythematosus (SLE), spondyloarthritis (SpA), gout
Table 3.7 Rheumatic
diseases in which RAPID3
has been reported to be
informative about patient
status and/or change in status
Rheumatic disease(s) References
Systemic lupus erythematosus Askanase et al. [ 103 ]
Castrejon et al. [ 104 ]
Osteoarthritis Castrejon et al. [ 104 ]
Ankylosing spondylitis Castrejon et al. [ 104 ]
Danve et al. [ 105 ]
Cinar et al. [ 106 ]
Michelsen et al. [ 107 ]
Park et al. [ 108 ]
Psoriatic arthritis Castrejon et al. [ 104 ]
Gout Castrejon et al. [ 104 ]
Vasculitis Annapureddy et al. [ 109 ]
Fibromyalgia Callahan et al. [ 112 ]
DeWalt et al. [ 61 ]
Pincus et al. [ 63 ]
Other Castrejon et al. [ 104 ]
Pincus et al. [ 110 ]A 4-Page MDHAQ: Patient Questionnaires to Provide
a Standard, “Scientifi c” Medical History for Updating
by Patients and Doctors, Rather Than Narrative Descriptions
As noted earlier, many physicians include an “intake” patient questionnaire at initial
visits. However, few intake questionnaires include quantitative scores analogous to
laboratory tests, or record narrative information in a standard , “scientifi c,”
3 PROMs (MDHAQ/RAPID3) and Physician RheuMetric Measures